Skip to main content

Advertisement

Table 1 Baseline characteristics of participates in the two groups

From: Serial coronary computed tomography angiography-verified coronary plaque progression: comparison of stented patients with or without diabetes

Characteristics DM (n = 36) Non-DM (n = 62) P-value
Age, y 69.6 ± 10.3 70.0 ± 11.5 0.389
Male 30 (83.3) 52 (83.9) 0.945
BMI, kg/m2 24.4 ± 3.8 23.1 ± 2.7 0.038
Systolic BP, mmHg 141.9 ± 36.6 132.8 ± 19.8 0.287
Diastolic BP, mmHg 81.6 ± 12.2 79.2 ± 8.3 0.447
Hypertension 26 (72.2) 36 (58.1) 0.161
Dyslipidemia 9 (25) 10 (16.1) 0.284
Current smoking 11 (30.6) 21 (33.9) 0.736
CVD 8 (22.2) 7 (11.3) 0.147
CAD family history 4 (11.1) 5 (8.1) 0.888
Chest pain 22 (61.1) 42 (67.7) 0.506
Anti-diabetic treatment
 Insulin 9 (25.0)
 Metformin 13 (36.1)
 Sulfonylurea 5 (13.9)
 α-Glucosidase inhibitor 14 (38.9)
 Non-drug 2 (5.5)
Statins at discharge 29 (80.6) 47 (75.8) 0.120
Clopidogrel/ticlopidine at discharge 36 (100) 62 (100)
Inter-scan period, y 1.8 (1–3.5) 1 (0.5–2.5) 0.171
No. of stented vessel/patients 1 (1–2) 1 (1–2) 0.235
No. of stented lesions/patients 2 (1–3.75) 2 (1–2.25) 0.235
Number of stented segments
 1 15 (41.7) 30 (48.4) 0.520
 2 8 (22.2) 17 (27.4) 0.569
 3 4 (11.1) 6 (9.7) 1
 ≥ 4 9 (25) 9 (14.5) 0.196
Number of stented vessels
 1 22 (61.6) 44 (71.0) 0.316
 2 9 (25) 15 (24.2) 0.929
 ≥ 3 5 (13.9) 3 (4.8) 0.139
Stent site
 LM 3 (8.3) 4 (6.5) 0.705
 LAD 25 (69.4) 35 (56.5) 0.203
 RCA 18 (50) 24 (38.7) 0.276
 LCx 10 (27.8) 17 (27.4) 0.969
  1. Values are expressed as mean ± SD, median (interquartile range) or n (%)
  2. BP blood pressure, CVD cerebrovascular disease, BMI body mass index, CAD coronary artery disease, LM left main, LAD left anterior descending, RCA right coronary artery, LCx left circumflex